XML 20 R24.htm IDEA: XBRL DOCUMENT v3.20.1
LOSS PER SHARE
 3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
LOSS PER SHARE
LOSS PER SHARE
Loss per share attributable to Bausch Health Companies Inc. were calculated as follows:
 
Three Months Ended
March 31,
(in millions, except per share amounts)
2020
 
2019
Net loss attributable to Bausch Health Companies Inc.
$
(152
)
 
$
(52
)
 
 
 
 
Basic and diluted weighted-average common shares outstanding
353.4

 
351.3

 
 
 
 
Basic and diluted loss per share attributable to Bausch Health Companies Inc.
$
(0.43
)
 
$
(0.15
)

During the three months ended March 31, 2020 and 2019, all potential common shares issuable for stock options and RSUs were excluded from the calculation of diluted loss per share, as the effect of including them would have been anti-dilutive. The dilutive effect of potential common shares issuable for stock options and RSUs on the weighted-average number of common shares outstanding would have been approximately 5,207,000 and 4,920,000 common shares for the three months ended March 31, 2020 and 2019, respectively.
During the three months ended March 31, 2020 and 2019, time-based RSUs, performance-based RSUs and stock options to purchase approximately 9,561,000 and 5,370,000 common shares, respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive under the treasury stock method.